The NVIDIA and Eli Lilly co-innovation lab announced January 12, 2026 at the JPM Healthcare Conference is one of the largest disclosed AI collaborations in pharma. It also extends a relationship that has been building as NVIDIA deepens ties across the pharma and life sciences sectors. Framed as up to $1 billion over five years,…
How digital twins could support more affordable Alzheimer’s research
Alzheimer’s clinical trials are among the most challenging and expensive studies to conduct with a 2021 study pegging the total costs since 1995 at $42.5 billion. Phase 3 trials are the biggest cost drivers, involving hundreds or thousands of participants. “We’re talking about studies with sometimes two thousand people per phase three clinical trial in…
Unlearn CEO: Digital twins could slash clinical trial patient enrollment by 25% or more
The startup Unlearn embodies several trendy AI characteristics. Generative AI company? Check. San Francisco headquarters? Check. Aims to disrupt drug development (specifically, clinical trials) with AI? Check. Prominent AI leadership? Check. Mira Murati, the high-profile CTO of OpenAI, joined Unlearn’s board of directors in 2023. But the company’s pedigree is unique. The firm was founded…